Is Serum Pregnancy-Associated Plasma Protein A Really a Potential Marker of Atherosclerotic Carotid Plaque Stability?

European Journal of Vascular and Endovascular Surgery

Volumn 39, Issue 6, 2010, Pages 668-675

  Heider, P ^a   Pfaffle N ^a   Pelisek, J ^a   Wildgruber, M ^a   Poppert, H ^a   Rudelius, M ^b   Eckstein, H H ^a  

^a Department of Vascular Surgery ^*  (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Carotid atherosclerosis; Metalloproteinase; Plaque stability; Pregnancy associated plasma protein A

Indexed keywords

CD68 ANTIGEN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOAM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID STENOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77952875591     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.03.012     Document Type: Article

References (29)

1. Loree H.M., Kamm R.D., Stringfellow R.G., and Lee R.T. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 71 4 (1992) 850-858
2. Cola C., Clementi E., Biondi-Zoccai G., and Sangiorgi G. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events. Acta Chir Belg 107 2 (2007) 129-142
3. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes Jr. D.R., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 14 (2001) 1022-1029
4. Cosin-Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., Cole D., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109 14 (2004) 1724-1728
5. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 9113 (1998) 1379-1387
6. Pai J.K., Curhan G.C., Cannuscio C.C., Rifai N., Ridker P.M., and Rimm E.B. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 48 10 (2002) 1781-1784
7. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 8 Suppl (2006) C13-C18
8. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 3 (2001) 365-372
9. Li X., Liu Q., Zhou T., Zhao S., and Zhou S. PAPP-A: a possible pathogenic link to the instability of atherosclerotic plaque. Med Hypotheses 70 3 (2008) 597-599
10. Lawrence J.B., Oxvig C., Overgaard M.T., Sottrup-Jensen L., Gleich G.J., Hays L.G., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 96 6 (1999) 3149-3153
11. Overgaard M.T., Haaning J., Boldt H.B., Olsen I.M., Laursen L.S., Christiansen M., et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275 40 (2000) 31128-31133
12. Qin Q.P., Christiansen M., Oxvig C., Pettersson K., Sottrup-Jensen L., Koch C., et al. Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down's syndrome. Clin Chem 43 12 (1997) 2323-2332
13. Conover C.A., Harrington S.C., and Bale L.K. Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Horm IGF Res 18 3 (2008) 213-220
14. Bayes-Genis A., Schwartz R.S., Lewis D.A., Overgaard M.T., Christiansen M., Oxvig C., et al. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 21 3 (2001) 335-341
15. Boldt H.B., and Conover C.A. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm IGF Res (2007)
16. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., Ferrer J., and Vargas M. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction. Clin Biochem 38 2 (2005) 180-182
17. Galis Z.S., Sukhova G.K., Lark M.W., and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94 6 (1994) 2493-2503
18. Nikkari S.T., O'Brien K.D., Ferguson M., Hatsukami T., Welgus H.G., Alpers C.E., et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92 6 (1995) 1393-1398
19. Elesber A.A., Conover C.A., Denktas A.E., Lennon R.J., Holmes Jr. D.R., Overgaard M.T., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 27 14 (2006) 1678-1684
20. Stulc T., Malbohan I., Malik J., Fialova L., Soukupova J., and Ceska R. Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment. Am Heart J 146 6 (2003) E21
21. Sangiorgi G., Mauriello A., Bonanno E., Oxvig C., Conover C.A., Christiansen M., et al. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol 47 11 (2006) 2201-2211
22. Glerup S., Boldt H.B., Overgaard M.T., Sottrup-Jensen L., Giudice L.C., and Oxvig C. Proteinase Inhibition by Proform of Eosinophil Major Basic Protein (pro-MBP) Is a Multistep Process of Intra- and Intermolecular Disulfide Rearrangements. J Biol Chem 280 11 (2005) 9823-9832
23. Miedema M.D., Conover C.A., MacDonald H., Harrington S.C., Oberg D., Wilson D., et al. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Am J Cardiol 101 1 (2008) 35-39
24. Conover C.A., Harrington S.C., Bale L.K., and Oxvig C. Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. Am J Physiol Heart Circ Physiol 292 2 (2007) H994-H1000
25. Qin Q.P., Kokkala S., Lund J., Tamm N., Voipio-Pulkki L.M., and Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 51 1 (2005) 75-83
26. Harrington S.C., Simari R.D., and Conover C.A. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 100 12 (2007) 1696-1702
27. Consuegra-Sanchez L., Fredericks S., and Kaski J.C. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis 203 2 (2009) 346-352
28. Stewart C.E., and Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76 4 (1996) 1005-1026
29. Madjid M., Zarrabi A., Litovsky S., Willerson J.T., and Casscells W. Finding vulnerable atherosclerotic plaques: is it worth the effort?. Arterioscler Thromb Vasc Biol. 24 10 (2004) 1775-1782